Medicare Enrolled
Dr. Julio Bravo, M.D.
Optician · Winston Salem, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bravo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bravo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bravo
Dr. Julio Bravo is an optician specialist in Winston Salem, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bravo performed 34,379 Medicare services across 1,285 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bravo received a total of $50,001 from 40 pharmaceutical and/or device companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bravo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in NC
$50,001 industry payments
Medicare Practice Summary
Medicare Utilization ↗34,379
Medicare services
Top 2% in NC for optician
1,285
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,719 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
15,600 | $4 | $15 |
| Tocilizumab injection (Actemra) | 10,240 | $5 | $11 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
4,700 | $10 | $50 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
1,675 | $34 | $90 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
308 | $17 | $55 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
195 | $8 | $12 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
157 | $12 | $34 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
157 | $5 | $18 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
155 | $3 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $92 | $250 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
119 | $10 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
114 | $108 | $320 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
111 | $7 | $25 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
84 | $11 | $30 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
77 | $12 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
75 | $10 | $35 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
53 | $69 | $215 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
52 | $13 | $45 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
51 | $91 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
51 | $66 | $175 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
44 | $13 | $50 |
| Measurement of dna antibody, single stranded | 44 | $11 | $45 |
| Rheumatoid factor level | 43 | $6 | $20 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
43 | $46 | $130 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
23 | $6 | $22 |
| Tuberculosis blood test (gamma interferon) A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels. |
20 | $61 | $150 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
20 | $18 | $150 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
18 | $4 | $15 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
18 | $12 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.8% high complexity
75.4% medium
5.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$50,001
Total received (2018-2024)
Avg $7,143/year across 7 years
Top 4% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
687
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,014 (74.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,987 (26.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,104
2023
$3,605
2022
$21,085
2021
$13,585
2020
$4,525
2019
$801
2018
$3,297
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$499
Amgen Inc.
$466
Janssen Biotech, Inc.
$420
UCB, Inc.
$379
Novartis Pharmaceuticals Corporation
$267
AstraZeneca Pharmaceuticals LP
$223
Mallinckrodt Hospital Products Inc.
$181
Lilly USA, LLC
$175
SANOFI-AVENTIS U.S. LLC
$99
Boston Scientific Corporation
$79
GENZYME CORPORATION
$73
GlaxoSmithKline, LLC.
$52
PFIZER INC.
$44
E.R. Squibb & Sons, L.L.C.
$39
Aurinia Pharma U.S., Inc.
$22
Sandoz Inc.
$20
SOBI, INC
$18
Kiniksa Pharmaceuticals International, plc
$17
Alexion Pharmaceuticals, Inc.
$16
Novo Nordisk Inc
$16
Top 3 companies account for 44.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$24,742
GlaxoSmithKline, LLC.
$14,100
AbbVie Inc.
$1,622
UCB, Inc.
$1,479
ABBVIE INC.
$1,043
Lilly USA, LLC
$925
Janssen Biotech, Inc.
$797
AbbVie, Inc.
$613
AstraZeneca Pharmaceuticals LP
$576
Novartis Pharmaceuticals Corporation
$572
PFIZER INC.
$553
Janssen Scientific Affairs, LLC
$422
Regeneron Healthcare Solutions, Inc.
$270
Horizon Pharma plc
$233
Mallinckrodt Hospital Products Inc.
$224
Aurinia Pharma U.S., Inc.
$217
Celgene Corporation
$194
E.R. Squibb & Sons, L.L.C.
$173
GENZYME CORPORATION
$156
Genentech USA, Inc.
$117
Ironwood Pharmaceuticals, Inc
$113
Radius Health, Inc.
$110
Boston Scientific Corporation
$105
SANOFI-AVENTIS U.S. LLC
$99
BOSTON SCIENTIFIC CORPORATION
$79
Fresenius Kabi USA, LLC
$68
Sandoz Inc.
$63
Organon LLC
$54
Alexion Pharmaceuticals, Inc.
$49
Grifols USA, LLC
$37
Takeda Pharmaceuticals U.S.A., Inc.
$37
Horizon Therapeutics plc
$28
Vapotherm Inc
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
SOBI, INC
$18
Kiniksa Pharmaceuticals International, plc
$17
Novo Nordisk Inc
$16
Octapharma USA, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
MEDAC PHARMA, INC.
$11
Top 3 companies account for 80.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUEXIS · DUPIXENT DUPILUMAB INJECTION · DUZALLO · EMGALITY · EVENITY · Enbrel · FORTEO · GENERAL PAIN MANAGEMENT · Gamunex-C · General - Pain Management · HUMIRA · HYRIMOZ · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MOUNJARO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PENNSAID · Precision Flow · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Trintellix · Truxima · Tymlos · Uloric · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for optician in NC.
Geographic Context
Opticians within 10 mi
64
Per 100K population
16.5
County median income
$65,541
Nearest hospital
OLD VINEYARD YOUTH SERVICES
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bravo is a mixed practice specialist, with above-average Medicare volume (top 2% in NC), with speaking/promotional industry engagement in the top 4% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bravo experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Bravo performed 15,600 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bravo receive payments from pharmaceutical companies?
Yes. Dr. Bravo received a total of $50,001 from 40 companies across 687 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bravo's costs compare to other opticians in Winston Salem?
Dr. Bravo's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bravo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Winston Salem
Browse opticians in Winston Salem ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology